Unlock instant, AI-driven research and patent intelligence for your innovation.

L-phenylglycine derivative and application thereof

A technology of phenylglycine and its derivatives, which is applied in the chemical field, can solve the problems of high therapeutic dose, etc., and achieve the effect of increasing utilization and improving insulin sensitivity

Active Publication Date: 2014-03-26
SOUTHWEST UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have shown that the hypoglycemic effect of nateglinide is 50 times that of D-phenylalanine, but nateglinide is an ultra-short-acting drug that needs to be administered 3 to 4 times a day with a large therapeutic dose (60 ~120mg / time)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • L-phenylglycine derivative and application thereof
  • L-phenylglycine derivative and application thereof
  • L-phenylglycine derivative and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1, the preparation of target compound 1

[0025]

[0026] 1. Preparation of Intermediate M1

[0027] M1-a(R 1 =Fmoc) and M1-b(R 1 For the preparation of =Z), see Chinese patent application CN 101633626A.

[0028] M1-c(R 1 =Ts) preparation: in 250mL round bottom flask, add SM 50.0mmol and mass fraction be 10% Na 2 CO 3 solution, stirred to dissolve, cooled in an ice bath, slowly added dropwise 50 mL of Ts-Cl 75 mmol acetone solution, after the addition was completed, the temperature was raised to 18°C ​​and the reaction was stirred, and the pH was maintained at 9-11 during the reaction, and monitored by thin-layer chromatography (TLC). Reaction process, after 4 hours, the reaction was completed, cooled in an ice bath, adjusted to pH 5-6 with 2mol / L HCl, distilled off the organic solvent under reduced pressure, then added 120 mL of EtOAc, cooled in an ice bath, adjusted to pH 3 with 2mol / L HCl ~4, separate the EtOAc layer, extract the aqueous phase wit...

Embodiment 2

[0054] Embodiment two, the preparation of target compound 2

[0055]

[0056] In a 250 mL round bottom flask add R 5 x 1 H or DMF 2-10mL and anhydrous K 2 CO 3 , stirred, added 1b, stirred at 25-40°C, TLC monitored the reaction progress, A 5 After 1 hour, the reaction was completed. Add 100 mL of ice NaCl solution and 50-80 mL of EtOAc, cool in an ice bath, adjust the pH to 5-6 with 2 mol / L HCl, extract with EtOAc (3×30 mL), combine the organic layers, and wash with saturated NaCl solution to medium sex, anhydrous Na 2 SO 4 Dry, filter with suction, concentrate the filtrate under reduced pressure, and separate and purify by column chromatography to obtain 2. The specific preparation conditions and results are shown in Table 4.

[0057] Preparation conditions and results of Table 42

[0058]

[0059]

[0060]

[0061] 2a: m.p.92.7~99.1℃; (c 1.0 mg / mL, EtOAc); 1 H NMR (CDCl 3 , 300MHz) δ: 3.65(s, 3H, -COO CH 3 ), 3.92 (s, 2H, CO CH 2 ), 5.01~5.13 (m...

Embodiment 3

[0080] Embodiment three, the preparation of target compound 3

[0081]

[0082] Add 2 and THF 10-25mL into a 100mL round bottom flask, stir, cool in an ice bath, add 1mol / L LiOH solution to adjust the pH to 10-12, B 2 ℃ stirring reaction, TLC monitoring reaction progress, A 6 Hours later, the reaction was completed, cooled in an ice bath, adjusted to pH 5-6 with 2mol / L HCl, removed the solvent by rotary evaporation under reduced pressure, cooled in an ice bath, adjusted to pH 3-4 with 2mol / L HCl, and extracted the aqueous phase with EtOAc for 3 times, the combined organic layers were washed with saturated NaCl solution, anhydrous NaCl 2 SO 4 After drying and suction filtration, the filtrate was distilled off under reduced pressure to remove EtOAc to obtain 3. The specific preparation conditions and results are shown in Table 5.

[0083] Preparation conditions and results of Table 53

[0084]

[0085]

[0086] 3a: m.p.145.3~154.2℃; (c 1.0mg / mL, DMF); 1 H NMR (D...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an L-phenylglycine derivative shown in a formula I, wherein in the formula, R1 is an amino-protecting group, R2 is -NO2, -NH2 or -NHCO(CH2)nR4, n=1-8, R4 is hydrogen, halogen, hydroxy, acyloxy, C1-C8 alkoxy, sulfhydryl, substituted sulfhydryl, amino, substituted amino or nitrogen-containing heterocyclic group, R3 is -OR5 or NR6R7, R5 is hydrogen, C1-C8 alkyl or substituted C1-C8 alkyl, R6 and R7 independently are hydrogen, hydroxy, C1-C8 alkyl or substituted C1-C8 alkyl. The L-phenylglycine derivative provided by the invention has certain PPRE agonistic activity, and the relative PPRE agonistic activity of part of the compound reaches to 32.91 to 120.42 %. The L-phenylglycine derivative can be used for preparing a PPRE agonist and also is a good precursor molecule of anti-diabetic drugs.

Description

technical field [0001] The invention belongs to the field of chemistry and relates to the design, synthesis and antidiabetic activity research of novel L-phenylglycine derivatives. Background technique [0002] Diabetes is a chronic life-long disease that seriously threatens human health. More than 90% of diabetic patients are type 2 diabetes, which is characterized by decreased insulin secretion, insulin resistance and increased liver glucose, leading to disorders of glucose metabolism in the body. Although there are many drugs for the treatment of diabetes, most of them have certain toxic and side effects. It is still an arduous task for chemical and pharmaceutical workers to prepare new antidiabetic drugs with novel structures from cheap and easy-to-obtain natural raw materials and relatively simple synthetic methods. [0003] In recent years, medicinal chemists have made great progress in the study of drugs for the treatment of type 2 diabetes. Among them, Nateglinide, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C271/22C07C269/06C07C311/19C07C303/40C07D235/28C07D261/16C07D235/16C07D209/48C07D295/185C07D249/18C07D295/15C07D257/04C07D239/54C07D231/12A61K31/27A61K31/216A61K31/4184A61K31/4035A61K31/495A61K31/4192A61K31/41A61K31/513A61K31/415A61K31/42A61P3/10
CPCY02P20/55
Inventor 杨大成晏菊芳范莉陈欣苏小燕李华冲
Owner SOUTHWEST UNIV